InVivoMAb anti-mouse CD28

Pallandre JR, Borg C, Rognan D, et al. Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors. Eur J Med Chem. 2015,103:163-74. doi: 10.1016/j.ejmech.2015.08.054

Klimatcheva E, Pandina T, Reilly C, et al. CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunol. 2015,16(1):6. doi: 10.1186/s12865-015-0068-1

Huang Y, Clarke F, Karimi M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015,125(3):1019-32. doi: 10.1172/JCI77278

Bertin S, Aoki-Nonaka Y, de Jong PR, et al. The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4⁺ T cells. Nat Immunol. 2014,15(11):1055-1063. doi: 10.1038/ni.3009

Bertin S, Lozano-Ruiz B, Bachiller V, et al. Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice. Mucosal Immunol. 2015,8(3):505-15. doi: 10.1038/mi.2014.84

Végran F, Berger H, Boidot R, et al. The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nat Immunol. 2014,15(8):758-66. doi: 10.1038/ni.2925

Heinemann C, Heink S, Petermann F, et al. IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1. Nat Commun. 2014,5:3770. doi: 10.1038/ncomms4770

Berger H, Végran F, Chikh M, et al. SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth. Cancer Res. 2013,73(12):3578-90. doi: 10.1158/0008-5472.CAN-12-4018

Chen EJ, Shaffer MH, Williamson EK, et al. Ezrin and moesin are required for efficient T cell adhesion and homing to lymphoid organs. PLoS One. 2013,8(2):e52368. doi: 10.1371/journal.pone.0052368

Nowak EC, Weaver CT, Turner H, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med. 2009,206(8):1653-60. doi: 10.1084/jem.20090246